NxStage

NxStage Medical, Inc. ( [2]) is an American company that develops, manufactures, and markets systems for the treatment of chronic kidney disease, acute kidney injury, and hypervolemia. It is a subsidiary of Fresenius Medical Care. System One, a portable hemodialysis system, is the company's primary product.[1]

History

The company was founded by C. David Finch, Jr., MD[3] and Jeffrey H. Burbank in December 1998.[4]

In 2003, the company launched System One in the critical care market. It received Food and Drug Administration clearance for home hemodialysis in June 2005.[5]

In October 2005, the company became a public company via an initial public offering.[6]

On November 2, 2005, the company received the Nixon Peabody/Smith&Nephew Medical Device Innovation Award in the Start-Up category from the Massachusetts Medical Device Industry Council (MassMEDIC).[7]

In December 2014, the company received Food and Drug Administration clearance for System One to be used overnight while patients are sleeping.[8]

In August 2017, the company received Food and Drug Administration clearance for System One for solo home hemodialysis, without a care partner, during waking hours.[9]

In February 2019, the company was acquired by Fresenius Medical Care.[10][11]

External links